Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jolanta Sawicka-Powierza is active.

Publication


Featured researches published by Jolanta Sawicka-Powierza.


Scandinavian Journal of Primary Health Care | 2002

Perception of risk information. Similarities and differences between Danish and Polish general practitioners

Jørgen Nexøe; Ołtarzewska Am; Jolanta Sawicka-Powierza; Jakob Kragstrup; Ivar Sønbø Kristiansen

Objective - The objective of the study was to gain better insight into how general practitioners (GPs) perceive risk reduction and the way this perception may be influenced by healthcare environment. Design - Questionnaires with clinical episodes were sent to Danish and Polish GPs, who were randomised into four groups, each receiving the same case story with differently phrased information about risk reduction achieved through medical treatment. The GPs were asked whether they would recommend medical treatment, knowing the case story and expected risk reduction. Subjects - Danish and Polish GPs. Results - A greater proportion of Polish GPs than Danish GPs would definitely or probably recommend treatment (93% versus 72%; p < 0.001). Both groups of doctors were more inclined to recommend treatment when the achievable benefits were presented in terms of relative risk reduction rather than absolute risk reduction or number needed to treat. Conclusion - Neither information on number needed to treat nor relative risk reduction alone provides doctors with all the information they need to recommend treatment or prevention to their patients. The present study showed that the professional handling of risk information is affected by differences produced by healthcare cultures.


Aids Care-psychological and Socio-medical Aspects of Aids\/hiv | 2009

Which factors hinder the decision of Polish HIV-positive patients to take up antiretroviral therapy?

Dorota Rogowska-Szadkowska; Sławomir Chlabicz; M.A. Oltarzewska; Jolanta Sawicka-Powierza

Abstract The implementation of highly active antiretroviral therapy (HAART) in 1996 has significantly reduced mortality and morbidity for HIV-positive patients worldwide. However not all eligible persons start HAART. To identify reasons for therapy refusal by HIV-positive persons we performed a questionnaire study. The investigation was conducted among 321 HIV-positive individuals and focused on the decision to take up antiretroviral treatment. Out of 71 untreated patients, 34 (47.9%) admitted that in their case the therapy was not indicated, whereas 20 (28.3%) were afraid of potential side effects that might change their appearance, e.g. face lipoatrophy. Only the treated patients had been prepared to take up therapy, although 17 patients (6.0%) had not received any explanation of the therapy principles, aims or necessity to comply with medication regime. The therapy is generally not discussed with the patients for whom it is not currently indicated, which may contribute to the fixation of fears and prejudices. Doctors who treat HIV-positive patients should be aware of the prejudices and fears their patients have towards antiretroviral therapy in order to react properly and by means of the available antiretroviral drugs help prolong life and improve its quality.


Chemotherapy | 2005

Management of Sore Throat by Family Physicians in Northeastern Poland: Possible Benefits of Applying Clinical Algorithm

Sławomir Chlabicz; Ołtarzewska Am; Jolanta Sawicka-Powierza

Background: The objective of this study was to describe current sore throat management practices among family physicians and to estimate potential benefits of applying clinical algorithm – Centor’s scale (presence of tonsillar exudates, fever, lymphadenopathy and absence of cough) in decision-making process. Methods: Each of 44 participating family physicians was asked to fill in questionnaires for 30 consecutive patients with respiratory tract infection. Results: Almost all decisions were made on clinical grounds. Among 169 adult patients with the clinical diagnosis of bacterial pharyngitis only 55% fulfilled 3 or more criteria on Centor’s scale. Conclusions: Family physicians overdiagnose bacterial pharyngitis. Screening adult patients with Centor’s criteria would probably lead to a reduction in the prescribing of antibiotics.


Oxidative Medicine and Cellular Longevity | 2017

Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome

Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mateusz Maciejczyk; Halina Car; Jolanta Sawicka-Powierza; Radoslaw Motkowski; Joanna Karpińska; Marta Hryniewicka; Anna Zalewska; Małgorzata Pac; Beata Wolska-Kusnierz; Ewa Bernatowska; Bożena Mikołuć

This study compared the antioxidant status and major lipophilic antioxidants in patients with ataxia-telangiectasia (AT) and Nijmegen breakage syndrome (NBS). Total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), and concentrations of coenzyme Q10 (CoQ10) and vitamins A and E were estimated in the plasma of 22 patients with AT, 12 children with NBS, and the healthy controls. In AT patients, TAS (median 261.7 μmol/L) was statistically lower but TOS (496.8 μmol/L) was significantly elevated in comparison with the healthy group (312.7 μmol/L and 311.2 μmol/L, resp.). Tocopherol (0.8 μg/mL) and CoQ10 (0.1 μg/mL) were reduced in AT patients versus control (1.4 μg/mL and 0.3 μg/mL, resp.). NBS patients also displayed statistically lower TAS levels (290.3 μmol/L), while TOS (404.8 μmol/L) was comparable to the controls. We found that in NBS patients retinol concentration (0.1 μg/mL) was highly elevated and CoQ10 (0.1 μg/mL) was significantly lower in comparison with those in the healthy group. Our study confirms disturbances in redox homeostasis in AT and NBS patients and indicates a need for diagnosing oxidative stress in those cases as a potential disease biomarker. Decreased CoQ10 concentration found in NBS and AT indicates a need for possible supplementation.


Advances in Medical Sciences | 2014

Does thrombopoiesis in multiple myeloma patients depend on the stage of the disease

Joanna Kamińska; Olga M. Koper; Maria Mantur; Joanna Matowicka-Karna; Jolanta Sawicka-Powierza; Jarosław Sokołowski; Agnieszka Kostur; Agnieszka Kulczyńska; Janusz Kloczko; Halina Kemona

PURPOSE Infiltration of the bone marrow by neoplastic plasmocytes in multiple myeloma (MM) patients might impair megakaryocytopoiesis. The aim of the study was to evaluate stage-dependent platelet count (PLT) and thrombopoietin (TPO) concentration in comparison to the control group. We also wanted to establish whether TPO might be recognized as a marker of the stage of the disease. MATERIAL/METHODS The study group consisted of 41 patients (mean age 67.7) with newly diagnosed MM prior to treatment and categorized according to the Durie and Salmon diagnostic classification. The control group consisted of 30 healthy subjects (mean age 65.5). PLT, WBC, RBC and Hb were measured with the use of the haematological analyser. TPO was assayed with the use of ELISA and albumin with the use of the immunonephelometry method. The number of plasma cells in the bone marrow was evaluated in bone marrow smears under light microscopy. RESULTS PLT was not statistically different as compared the control groups, but was stage-dependent. Thrombocytopenia was observed in the III stage of MM. TPO median was significantly higher in study group than in healthy subjects and it was increasing considerably with the stage of the disease. TPO concentration was negatively correlated with albumin and PLT. AUC for TPO was 0.9764. The number of plasma cells in the bone marrow was considerably increasing with the stage of the disease. CONCLUSIONS PLT and TPO in MM patients were stage-dependent. Elevated TPO concentration in MM patients might be an unfavourable marker of the stage of the disease.


Frontiers in Endocrinology | 2018

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

Jolanta Sawicka-Powierza; Jerzy Konstantynowicz; Ewa Jablonska; Beata Zelazowska-Rutkowska; Wojciech Jelski; Pawel Abramowicz; Caroline Sasinowski; Sławomir Chlabicz

Objective Both vitamin D and K2 are involved in a number of metabolic processes, including bone metabolism; however, associations between the vitamins are not fully understood. The aim of the study was to evaluate serum concentrations of 25-hydroxyvitamin D [25(OH)D] in adult patients receiving long-term acenocoumarol (AC) treatment. Participants and methods In this cross-sectional study, 58 Caucasian patients (31 women, 27 men) with a median age of 65 years receiving long-term AC therapy were evaluated and compared with 35 age- and gender-matched healthy controls. The AC treatment was used due to recurrent venous thromboembolism (34.5%), atrial fibrillation (31%), or mechanical heart valve prostheses (34.5%). Medical records and a questionnaire were used to obtain information about chronic diseases, smoking habits, and the duration of therapy and weekly dose of AC. Anthropometric measurements were performed, and serum concentration of 25(OH)D and total alkaline phosphatase (ALP) activity were measured. Results Among the 58 patients receiving long-term AC treatment, a high proportion (46.6%) demonstrated significant vitamin D deficiency with concentrations of 25(OH)D lower than 20 ng/mL. The median concentration of 25(OH)D in subjects receiving AC was significantly lower compared to the control group [20.4 (17.4; 26.1) vs. 28.2 (24; 32.7); p < 0.001]. No differences were found between women and men receiving AC therapy. In patients receiving AC, a negative correlation was found between the concentration of 25(OH)D and the weekly dose of AC (r = −0.337, p = 0.01). Patients with concentrations of 25(OH)D < 20 ng/mL were found to have a significantly higher median dose of AC, compared to those with concentrations of 25(OH)D ≥ 20 ng/mL [21 (17; 31) vs. 17 (12; 28); p = 0.045]. Conclusion In conclusion, treatment with AC is associated with low 25-hydroxyvitamin D levels, although the path leading to this phenomenon is not entirely clear. Long-term administration of AC in adults may increase the risk of chronic vitamin D deficiency, thus, effective supplementation of vitamin D in these individuals needs careful consideration.


Journal of Clinical Medicine | 2018

Bone Metabolism Markers and Bone Mineral Density in Patients on Long-Term Acenocoumarol Treatment: A Cross-Sectional Study

Jolanta Sawicka-Powierza; Ewa Jablonska; Wioletta Ratajczak-Wrona; Dorota Rogowska-Szadkowska; Marzena Garley; Ołtarzewska Am; Sławomir Chlabicz; Jerzy Konstantynowicz

The aim of this study was to evaluate levels of osteocalcin (OC), osteoprotegerin (OPG) and total soluble receptor activator of nuclear factor-κB ligand (RANKL), and bone mineral density (BMD) in patients on long-term acenocoumarol (AC) treatment. The cross-sectional study was carried out in 42 patients treated long-term with AC and 28 control subjects. Serum concentrations of OC, OPG, and sRANKL were measured using enzyme linked immunosorbent assay (ELISA) kits, and BMD at the femoral neck and lumbar spine were assessed by dual energy X-ray absorptiometry. A significantly decreased concentration of OC was found in AC users compared to control subjects (4.94 ± 2.22 vs. 10.68 ± 4.5; p < 0.001). Levels of OPG, sRANKL logarithm (log), sRANKL/OPG log ratio, and BMD were comparable between. In female AC users, positive correlations between OC and RANKL log, and between OC and RANKL/OPG log ratio (p = 0.017; p = 0.005, respectively), and a negative correlation between OC and OPG (p = 0.027) were found. Long-term AC anticoagulation significantly decreases OC concentration, but does not affect other bone metabolism markers or BMD. Our results also suggest the possibility that long-term treatment with AC may alleviate bone resorption in postmenopausal women.


Journal of Cancer | 2018

Differences and similarities in the phenomenon of NETs formation in oral inflammation and in oral squamous cell carcinoma

Marzena Garley; Dorota Dziemiańczyk-Pakieła; Kamil Grubczak; Arkadiusz Surażyński; Dorota Dąbrowska; Wioletta Ratajczak-Wrona; Jolanta Sawicka-Powierza; Jan Borys; Marcin Moniuszko; Jerzy Pałka; Ewa Jablonska

Taking into account the previously reported relationship between inflammation and carcinogenesis, and the scant amount of data concerning the role of neutrophil extracellular traps (NETs) in carcinogenesis, we decided to study the process of extracellular trap formation in patients with inflammation as well as in patients with cancer occurring in the same location. For preliminary isolation of neutrophils (PMNs), we used Polymorphprep™, then sorted with Microbeads. The cells were recorded in the incubation chamber with a BD Pathway 855 microscope system. Flow cytometric data (MPO+ neutrophils) were acquired on FACSCalibur flow cytometer. Amounts of cfDNA were determined by Abcams Circulating DNA Quantification Kit. Neutrophils of patients with inflammation and of subjects with stage I/II oral squamous cell carcinoma (OSCC) produce increased amounts of NETs, while stage III/IV OSCC were comparable with the control group. In all of the studied groups of cells stimulation with LPS and rhIL-17 produced more NETs in relation to unstimulated cells. Neutrophil supernatant of inflammation patients and stage I/II cancer patients demonstrated the increased level of cfDNA, which decreased at stage III/IV. Patients with oral inflammations showed an increased rate of MPO+ neutrophils, which was lower than in stage I/II cancer patients and not significantly different than in Stage III/IV cancer patients and the control group. The direction of changes in NETs formation seems to be a new common element shared by inflammation and early stage cancer. Changes in the formation of NETs observed in patients with advanced cancer, other than an early phase or inflammation, indicate an alternative range of NETs involvement depending on different phases of this disease.


BMJ Open | 2018

Identifying important health system factors that influence primary care practitioners’ referrals for cancer suspicion: a European cross-sectional survey

Michael Harris; Peter Vedsted; Magdalena Esteva; Peter Murchie; Isabelle Aubin-Auger; Joseph Azuri; Mette Brekke; Krzysztof Buczkowski; Nicola Buono; Emiliana Costiug; Geert-Jan Dinant; Gergana Foreva; Svjetlana Gašparović Babić; Robert Hoffman; Eva Jakob; Tuomas H. Koskela; Mercè Marzo-Castillejo; Ana Luísa Neves; Davorina Petek; Marija Petek Šter; Jolanta Sawicka-Powierza; Antonius Schneider; Emmanouil Smyrnakis; Sven Streit; Hans Thulesius; Birgitta Weltermann; Gordon Taylor

Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe. These differences may be partly due to variations in access to investigations and specialists. However, evidence to explain how different national health systems influence primary care practitioners’ (PCPs’) referral decisions is lacking. This study analyses health system factors potentially influencing PCPs’ referral decision-making when consulting with patients who may have cancer, and how these vary between European countries. Design Based on a content-validity consensus, a list of 45 items relating to a PCP’s decisions to refer patients with potential cancer symptoms for further investigation was reduced to 20 items. An online questionnaire with the 20 items was answered by PCPs on a five-point Likert scale, indicating how much each item affected their own decision-making in patients that could have cancer. An exploratory factor analysis identified the factors underlying PCPs’ referral decision-making. Setting A primary care study; 25 participating centres in 20 European countries. Participants 1830 PCPs completed the survey. The median response rate for participating centres was 20.7%. Outcome measures The factors derived from items related to PCPs’ referral decision-making. Mean factor scores were produced for each country, allowing comparisons. Results Factor analysis identified five underlying factors: PCPs’ ability to refer; degree of direct patient access to secondary care; PCPs’ perceptions of being under pressure; expectations of PCPs’ role; and extent to which PCPs believe that quality comes before cost in their health systems. These accounted for 47.4% of the observed variance between individual responses. Conclusions Five healthcare system factors influencing PCPs’ referral decision-making in 20 European countries were identified. The factors varied considerably between European countries. Knowledge of these factors could assist development of health service policies to produce better cancer outcomes, and inform future research to compare national cancer diagnostic pathways and outcomes.


Archivum Immunologiae Et Therapiae Experimentalis | 2018

The Phenomenon of Neutrophil Extracellular Traps in Vascular Diseases

Dorota Dąbrowska; Ewa Jablonska; Marzena Garley; Jolanta Sawicka-Powierza; Karolina Nowak

Vascular diseases constitute a global health issue due to the increasing number of cases of patients with these diseases. The pathogenesis of the majority of these diseases, including atherosclerosis and thrombosis, is complex and not yet fully understood. One of the major causes for their occurrence can be immune disorders resulting in the development of a chronic inflammation within the vessels. In recent years, studies have placed emphasis on the role of neutrophils in the development of these diseases, i.e., the discovery of neutrophil extracellular traps (NETs) demonstrated that the structures released by the cells may contribute to the enhancement of inflammatory reactions and cell damage. This article summarizes current knowledge on the role of NETs during atherosclerosis, thrombosis and small-vessel vasculitis, especially in antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis (AAV).

Collaboration


Dive into the Jolanta Sawicka-Powierza's collaboration.

Top Co-Authors

Avatar

Sławomir Chlabicz

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Ołtarzewska Am

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Ewa Jablonska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Dorota Rogowska-Szadkowska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Marzena Garley

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Wioletta Ratajczak-Wrona

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Bożena Mikołuć

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Halina Car

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Janusz Kloczko

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Jaroslaw Piszcz

Medical University of Białystok

View shared research outputs
Researchain Logo
Decentralizing Knowledge